在雄性大鼠中对Regorafenib和青之间的相互作用进行药理动力学研究
Agnieszka Karbownik1, Danuta Szkutnik-Fiedler1, Filip Otto1
1Department of Clinical Pharmacy and Biopharmacy, Poznań University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
Pharmaceutics
|November 27, 2024
概括
降醇显著增加了对regorafenib的暴露,可能会恶化副作用. 雷戈拉菲尼布降低了青的水平,可能减少了癌症患者的止痛效果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物相互作用 药物相互作用
- 在瘤学瘤学.
背景情况:
- 临床实践中的多药性增加了药物相互作用的风险.
- 雷戈拉菲尼布 (REG) 和青 (PA) 经常用于癌症患者的疼痛管理.
研究的目的:
- 在大鼠中研究青对雷戈拉费尼布及其代谢物的药理动力学影响.
- 为了确定regorafenib对青及其代谢物的药理动力学的影响.
主要方法:
- 鼠被分为三个组:单独使用REG,单独使用PA,以及同时使用REG和PA.
- 超高性能液态染色学-并联质谱学 (UPLC-MS/MS) 和高性能液态染色学 (HPLC-UV) 用于量化药物和代谢物度.
- 使用非分区分析来计算药理动力学参数.
主要成果:
- 降醇的使用显著增加了regorafenib及其代谢物M-2和M-5的Cmax和AUC0-∞.
- 与雷戈拉费尼布的同时使用降低了白醇及其葡萄糖化代谢物 (GPA) 的AUC0-∞,但增加了其硫酸盐代谢物 (SPA) 的AUC0-∞.
结论:
- 青会增加对雷戈拉费尼布的暴露,从而可能增加副作用.
- 雷戈拉菲尼布减少了对的暴露,并加速了其消除,可能限制了镇痛效果.
- 这些发现突出了对癌症患者的潜在临床影响,这些患者同时接受止痛药和雷戈拉费尼布治疗.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
84
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
84
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
43
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
43
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
30
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
30
Factors Influencing Drug Absorption: Pharmaceutical Parameters
121
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
121
Renal Failure: Dose Adjustments
64
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
64


